Literature DB >> 24269695

Heat shock proteins: possible biomarkers in pulmonary and extrapulmonary tuberculosis.

Seema D Shekhawat1, Ruchika K Jain1, Hari M Gaherwar1, Hemant J Purohit2, Girdhar M Taori1, Hatim F Daginawala1, Rajpal S Kashyap3.   

Abstract

Tuberculosis (TB) and Tuberculous meningitis (TBM) caused by Mycobacterium tuberculosis (MTB) continue to be a major cause of morbidity and mortality. Therefore there is a need to explore potential biomarkers and heat shock proteins [Hsp(s)] could be one such candidate. We found that host (Hsp 25, Hsp 60, Hsp 70 and Hsp 90) and MTB Hsp(s) (Hsp 16, Hsp 65 and Hsp 71) to be an important feature of the immune response in human clinical samples of pulmonary and extrapulmonary TB patients and in MTB infected monocytes. Notably, the host (Hsp 25, Hsp 70 and Hsp 90) and MTB (Hsp 16, Hsp 65 and Hsp 71) Hsp(s) increases significantly in the clinical samples as well as in cell line model after TB infection. Collectively, results revealed that alteration in immune response leads to a change in the both host and MTB Hsp profile, highlighting them as possible biomarkers for the disease.
Copyright © 2013 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24269695     DOI: 10.1016/j.humimm.2013.11.007

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  2 in total

1.  Extraction and Separation of Mycobacterial Proteins.

Authors:  Megan Lucas; Joan M Ryan; Jackson Watkins; Kala Early; Nicole A Kruh-Garcia; Carolina Mehaffy; Karen M Dobos
Journal:  Methods Mol Biol       Date:  2021

2.  Investigation of Immune Biomarkers Using Subcutaneous Model of M. tuberculosis Infection in BALB/c Mice: A Preliminary Report.

Authors:  Aliabbas A Husain; Hatim F Daginawala; Shubangi R Warke; Devanand R Kalorey; Nitin V Kurkure; Hemant J Purohit; Girdhar M Taori; Rajpal S Kashyap
Journal:  Immune Netw       Date:  2015-04-23       Impact factor: 6.303

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.